|
Age (years), median (range)
|
64 (30–89)
|
74 (47–83)
|
0.060
|
|
Gender, n (%)
| | |
0.377
|
|
Male
|
44 (63.8)
|
10 (52.6)
| |
|
Female
|
25 (36.2)
|
9 (47.4)
| |
|
Event, n (%)
| | |
0.512
|
|
Stroke
|
62 (89.9)
|
18 (94.7)
| |
|
Transient ischemic attack
|
7 (10.1)
|
1 (5.3)
| |
|
Body mass index (kg/m2), median (range)
|
27 (19–49)
|
28 (23–44)
|
0.478
|
|
Comorbidity, n (%)
|
|
Hypertension
|
47 (68.1)
|
12 (63.2)
|
0.684
|
|
Diabetes mellitus
|
17 (24.6)
|
3 (15.8)
|
0.415
|
|
Vasculopathy
|
16 (23.2)
|
3 (15.8)
|
0.488
|
|
Heart failure
|
3 (4.3)
|
0
|
0.355
|
|
CHA2DS2-VASc score, median (range)
|
4 (2–7)
|
5 (2–7)
|
0.346
|
|
Score 2, n (%)
|
6 (8.7)
|
1 (5.3)
| |
|
Score 3, n (%)
|
16 (23.2)
|
4 (21.1)
| |
|
Score 4, n (%)
|
16 (23.2)
|
3 (15.8)
| |
|
Score 5, n (%)
|
17 (24.6)
|
5 (26.3)
| |
|
Score 6, n (%)
|
7 (10.1)
|
4 (21.1)
| |
|
Score 7, n (%)
|
7 (10.1)
|
2 (10.5)
| |
|
Extrasystole, n (%)
|
52 (75.4)
|
12 (63.2)
|
0.290
|
|
Number of drugs, median (range)
|
4 (1–14)
|
5 (2–8)
|
0.992
|
|
Smocking status, n (%)
| | |
0.720
|
|
Nonsmoker
|
37 (53.6)
|
12 (63.2)
| |
|
Smoker
|
21 (30.4)
|
4 (21.1)
| |
|
Ex-smoker
|
9 (13.0)
|
3 (15.8)
| |
|
No indication
|
2 (2.9)
|
0
| |
|
Observation period (months), median (range)
|
23 (1–33)
|
7 (1–32)
|
0.002
|
|
Recurrent stroke during observation period, n (%)
|
XX
|
XX
|
XX
|
